Antitrust Chronicle – Private Equity + CRESSE

I. PRIVATE EQUITY

Dear Readers,

What does competition law have to do with private equity investments? If you listen only to the investors, the answer is “not very much.” But in fact the authorities have a substantial interest in
determining whether a private equity transaction, like any other acquisition of stock or assets, has an adverse impact on competition. Are these private equity transactions in fact reportable, or do
they slide by the filing and waiting requirements? Does it matter if the private equity investor is seeking board membership, or to change management direction of the target? In this issue, our
authors look at these issues as they arise in the United States, the EU, Brazil and other jurisdictions. The companies investing may be private. But the impact of their actions implicates some basic and established public antitrust policies.

Kent Bernard

Fordham University School of Law

II. SELECTED ARTICLES FROM CRESSE 2017

This section of the January 2018 CPI Antitrust Chronicle includes articles based on presentations from Special Policy Sessions (“SPS”) of the 12th Annual CRESSE Conference organized from 30th
June – 2nd July 2017. CRESSE (www.cresse.info), is an international network of academics and other professionals, with an interest in Competition Policy and Sectoral Regulation. Every year

CRESSE organizes an international conference in Greece that is widely recognized as one of the top academic conferences in the economic…

ACCESS TO THIS ARTICLE IS RESTRICTED TO SUBSCRIBERS

Please sign in or join us
to access premium content!